Adi Ickowicz
Adi Ickowicz, BSc, ME, is an experienced expert in Clinical & Regulatory Affairs and Quality Assurance with over thirty years in the MedTech industry. As the former Founder and CEO of MedicSense Ltd., a consultancy firm specializing in clinical and regulatory affairs, he has helped companies navigate international regulatory requirements. His work focuses on developing tailored regulatory and clinical strategies, ensuring compliance with global standards, and assisting companies in meeting technical and regulatory demands for their medical devices.
Throughout his career, Adi has supported companies in managing regulatory submissions for the European Union (CE marking), the United States (FDA submissions), and other global markets. His understanding of technological requirements, regulatory needs, and clinical data collection has helped companies achieve regulatory approval and market entry.
Adi has led regulatory and clinical affairs departments in both established corporations and start-ups. Since 1995, he has been involved in regulatory submissions, internal and external audits, and due diligence evaluations.
Beyond consultancy, Adi has been active in education and professional training. He was a lecturer at Tel Aviv University’s Biomedical Engineering Department until 2012 and has contributed to Afeka College’s External Studies Department since 2016. Since 2012, he has also been a tutor for BSI (British Standards Institution).
In 2018, MedicSense was acquired by Genae/IQVIA (Belgium/USA), where Adi became Senior Principal for IQVIA MedTech’s European operations, focusing on regulatory strategies and business development.
From 2022 to 2024, Adi worked as Senior Principal and Business Development Officer for the MedTech unit of Asphalion Spain, providing regulatory guidance and strategic support. Since 2024, he is collaborating with for Summa Equity (Sweden) as an industrial advisor.
With a background in regulatory affairs, clinical strategy, business development, and education, Adi continues to contribute to the MedTech industry by supporting companies in regulatory compliance and market access.
